N4 Pharma (N4P)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

3.30p
   
  • Change Today:
      0.30p
  • 52 Week High: 3.50p
  • 52 Week Low: 0.43p
  • Currency: UK Pounds
  • Shares Issued: 101.46m
  • Volume: 594,266
  • Market Cap: £3.35m

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth
89.58% below the market average89.58% below the market average89.58% below the market average89.58% below the market average89.58% below the market average
78.38% below the sector average78.38% below the sector average78.38% below the sector average78.38% below the sector average78.38% below the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
73.71% above the market average73.71% above the market average73.71% above the market average73.71% above the market average73.71% above the market average
57.58% above the sector average57.58% above the sector average57.58% above the sector average57.58% above the sector average57.58% above the sector average
Price Book Ratio
64.01% below the market average64.01% below the market average64.01% below the market average64.01% below the market average64.01% below the market average
9.09% below the sector average9.09% below the sector average9.09% below the sector average9.09% below the sector average9.09% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
85.21% above the market average85.21% above the market average85.21% above the market average85.21% above the market average85.21% above the market average
50.88% above the sector average50.88% above the sector average50.88% above the sector average50.88% above the sector average50.88% above the sector average
Price Chg 3m
63.29% below the market average63.29% below the market average63.29% below the market average63.29% below the market average63.29% below the market average
43.86% below the sector average43.86% below the sector average43.86% below the sector average43.86% below the sector average43.86% below the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI Not Available
Momentum 20 Not Available

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
95.1% below the market average95.1% below the market average95.1% below the market average95.1% below the market average95.1% below the market average
69.23% below the sector average69.23% below the sector average69.23% below the sector average69.23% below the sector average69.23% below the sector average
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
58.11% below the market average58.11% below the market average58.11% below the market average58.11% below the market average58.11% below the market average
1.75% above the sector average1.75% above the sector average1.75% above the sector average1.75% above the sector average1.75% above the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
93.97% below the market average93.97% below the market average93.97% below the market average93.97% below the market average93.97% below the market average
79.49% below the sector average79.49% below the sector average79.49% below the sector average79.49% below the sector average79.49% below the sector average
Operating Profit Loss
51.59% below the market average51.59% below the market average51.59% below the market average51.59% below the market average51.59% below the market average
26.32% above the sector average26.32% above the sector average26.32% above the sector average26.32% above the sector average26.32% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets Not Available
Cash
68.48% below the market average68.48% below the market average68.48% below the market average68.48% below the market average68.48% below the market average
85.71% below the sector average85.71% below the sector average85.71% below the sector average85.71% below the sector average85.71% below the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y
46.61% below the market average46.61% below the market average46.61% below the market average46.61% below the market average46.61% below the market average
54.29% below the sector average54.29% below the sector average54.29% below the sector average54.29% below the sector average54.29% below the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

N4 Pharma Market Data

Currency UK Pounds
Share Price 3.30p
Change Today 0.30p
% Change 10.00 %
52 Week High 3.50p
52 Week Low 0.43p
Volume 594,266
Shares Issued 101.46m
Market Cap £3.35m

N4 Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
38.2% below the market average38.2% below the market average38.2% below the market average38.2% below the market average38.2% below the market average
68.42% below the sector average68.42% below the sector average68.42% below the sector average68.42% below the sector average68.42% below the sector average
Value
38.2% below the market average38.2% below the market average38.2% below the market average38.2% below the market average38.2% below the market average
68.42% below the sector average68.42% below the sector average68.42% below the sector average68.42% below the sector average68.42% below the sector average
Income Not Available
Growth
24.75% below the market average24.75% below the market average24.75% below the market average24.75% below the market average24.75% below the market average
35.14% below the sector average35.14% below the sector average35.14% below the sector average35.14% below the sector average35.14% below the sector average

N4 Pharma Dividends

No dividends found

Trades for 20-Jan-2020

Time Volume / Share Price
14:46 14,130 @ 3.45p
14:41 50,000 @ 3.31p
14:36 50,000 @ 3.41p
14:15 30,000 @ 3.40p
14:11 27,714 @ 3.50p

N4 Pharma Key Personnel

CEO Nigel Theobald

Top of Page